Target intelligence / Profile preview

HIV-1 envelope glycoprotein gp120 C4 region (gp120 C4)

Target
gp120 C4
Molecular classification
Viral envelope protein, Glycoprotein
01

Overview

The HIV-1 envelope glycoprotein gp120 C4 region is a highly conserved segment of the surface subunit (gp120) of the HIV-1 envelope (Env) protein. It is essential for viral entry into host cells, as it participates in the formation of the CD4 binding site and the bridging sheet, which interacts with chemokine coreceptors like CCR5 or CXCR4. Binding of gp120 to the CD4 receptor induces conformational changes in the C4 region and other domains, transitioning the Env trimer from a closed to an open state and exposing the coreceptor binding site. This region is a critical target for antiretroviral drugs, most notably the attachment inhibitor fostemsavir (and its active form temsavir), which binds to gp120 to prevent its interaction with CD4. Mutations within the C4 region, such as M426L and M434I, are significant because they can confer resistance to these inhibitors. Additionally, the C4 region is a target for various neutralizing antibodies, although the virus often shields this area through conformational masking and glycosylation to evade the immune system.

Other names
Fourth conserved region of gp120gp120 C4 domainC4 region of HIV-1 gp120HIV-1 gp120 C4
02

Mechanism of action

Attachment inhibition and conformational stabilization

03

Biological functions

Viral attachmentViral entryReceptor bindingCoreceptor bindingConformational transition
04

Disease associations

Infection
05

Safety considerations

Viral resistance developmentImmune evasionQTc prolongationImmune reconstitution inflammatory syndrome (IRIS)Hepatotoxicity in co-infected patients
06

Interacting drugs

Fostemsavir

1 more in the full profile.

07

Biomarkers

HIV-1 RNA viral loadCD4+ T-cell countgp120 M426L mutationgp120 M434I mutation

Beyond the preview

Go deeper on HIV-1 envelope glycoprotein gp120 C4 region (gp120 C4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV-1 envelope glycoprotein gp120 C4 region (gp120 C4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call